학술논문
HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors
Document Type
Article
Author
Source
In: Lung Cancer . (Lung Cancer, August 2022, 170:1-10)
Subject
Language
English
ISSN
18728332
01695002
01695002